Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Retinopathy of Prematurity Screening Criteria in Iran: New Screening Guidelines Publisher Pubmed



Roohipoor R1 ; Karkhaneh R1 ; Farahani A1 ; Ebrahimiadib N1 ; Modjtahedi B2 ; Fotouhi A3 ; Yaseri M3 ; Khodabande A1 ; Zarei M1 ; Fuladi MI1 ; Taheri A1 ; Esfahani MR1, 4 ; Loewenstein J2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Qazvin Square, South Kargar Street, Tehran, 1336616351, Iran
  2. 2. Retina Service, Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA, United States
  3. 3. Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Retina Service, Noor Eye Hospital, Tehran, Iran

Source: Archives of Disease in Childhood: Fetal and Neonatal Edition Published:2016


Abstract

Objective: To test the applicability of existing retinopathy of prematurity (ROP) guidelines on Iranian patients and to develop novel ROP screening criteria in Iran. Methods: Both eyes of 1932 infants born ≤37 weeks of gestation and/or weighting ≤3000 g were included in this prospective cohort study that was conducted across nine neonatal intensive care units and a tertiary eye hospital ROP clinic. The patients were examined for ROP and the need for treatment (type 1 ROP or worse). All the patients were screened 4 weeks after birth or at 31 weeks of postmenstrual age, whichever was later. The patients were followed until retinal vascularisation was completed or the patients reached 50 weeks of gestational age (GA) without prethreshold ROP. A receiver operating characteristic curve was used to determine the best screening criteria for ROP. Screening criteria from other countries were applied to our patient data to determine their ability to appropriately detect ROP. Main outcome measure: Patients with ROP requiring treatment. Results: The mean GA±SD and birth weight (BW)±SD of the screened patients were 32±2.7 weeks and 1713±516 g, respectively. Using criteria of GA≤32 weeks or BW ≤2000 yielded sensitivity and specificity of 100% and 26.7%, respectively, for treatment requiring ROP regardless of clinical comorbidities. Using screening recommendations of American Academy of Pediatrics would miss 25.4% of ROP and 8.4%ROP requiring treatment in our cohort. Conclusions: Other countries screening recommendations would result in a significant amount of missed cases of treatment requiring ROP when applied to Iran. As a result, we have proposed new guidelines for premature babies in Iran. © 2016, BMJ Publishing Group. All rights reserved.
Other Related Docs
10. A Review on Retinopathy of Prematurity, Medical Hypothesis, Discovery, and Innovation in Ophthalmology (2024)
12. Smartphones, Tele-Ophthalmology, and Vision 2020, International Journal of Ophthalmology (2017)